Literature DB >> 29376872

Characteristics of Cognitively Normal Mexican-Americans with Cognitive Complaints.

James R Hall1, April Wiechmann2, Leigh A Johnson3, Melissa Edwards4, Sid E O'Bryant3.   

Abstract

BACKGROUND: Subjective cognitive complaints in cognitively normal adults have been linked to later cognitive decline and dementia. Research on the characteristics of this group has been conducted on a variety of clinical and community-based populations. The current study focuses on the rapidly expanding population of Mexican-American elders.
OBJECTIVE: The objective of the study is the determination of characteristics of cognitively normal Mexican-Americans with cognitive complaints.
METHODS: Data on 319 cognitively normal participants in a large-scale community-based study of elderly Mexican-Americans (HABLE) were analyzed comparing those with cognitive complaints with those without on clinical characteristics, affective status, neuropsychological functioning, and proteomic markers.
RESULTS: Those expressing concern about cognitive decline scored lower on the MMSE, were more likely to have significantly more affective symptoms, higher levels of diabetic markers, poorer performance on attention and executive functioning, and a different pattern of inflammatory markers.
CONCLUSION: Although longitudinal research is needed to determine the impact of these differences on later cognition, possible targets for early intervention with Mexican-Americans were identified.

Entities:  

Keywords:  Affective symptoms; Mexican-Americans; biomarkers; subjective cognitive complaints

Mesh:

Substances:

Year:  2018        PMID: 29376872     DOI: 10.3233/JAD-170836

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  4 in total

1.  Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need.

Authors:  Ganesh M Babulal; Yakeel T Quiroz; Benedict C Albensi; Eider Arenaza-Urquijo; Arlene J Astell; Claudio Babiloni; Alex Bahar-Fuchs; Joanne Bell; Gene L Bowman; Adam M Brickman; Gaël Chételat; Carrie Ciro; Ann D Cohen; Peggye Dilworth-Anderson; Hiroko H Dodge; Simone Dreux; Steven Edland; Anna Esbensen; Lisbeth Evered; Michael Ewers; Keith N Fargo; Juan Fortea; Hector Gonzalez; Deborah R Gustafson; Elizabeth Head; James A Hendrix; Scott M Hofer; Leigh A Johnson; Roos Jutten; Kerry Kilborn; Krista L Lanctôt; Jennifer J Manly; Ralph N Martins; Michelle M Mielke; Martha Clare Morris; Melissa E Murray; Esther S Oh; Mario A Parra; Robert A Rissman; Catherine M Roe; Octavio A Santos; Nikolaos Scarmeas; Lon S Schneider; Nicole Schupf; Sietske Sikkes; Heather M Snyder; Hamid R Sohrabi; Yaakov Stern; Andre Strydom; Yi Tang; Graciela Muniz Terrera; Charlotte Teunissen; Debora Melo van Lent; Michael Weinborn; Linda Wesselman; Donna M Wilcock; Henrik Zetterberg; Sid E O'Bryant
Journal:  Alzheimers Dement       Date:  2018-12-13       Impact factor: 21.566

2.  Self-reported subjective cognitive decline is associated with global cognition in a community sample of Latinos/as/x living in the United States.

Authors:  Marina Z Nakhla; Lynn Cohen; David P Salmon; Denis S Smirnov; María J Marquine; Alison A Moore; Dawn M Schiehser; Zvinka Z Zlatar
Journal:  J Clin Exp Neuropsychol       Date:  2021-10-28       Impact factor: 2.475

3.  Levels of α-2 Macroglobulin in cognitively normal Mexican- Americans with Subjective Cognitive Decline: A HABLE Study.

Authors:  James R Hall; April R Wiechmann; Leigh A Johnson; Melissa L Edwards; Sid E O'Bryant
Journal:  Curr Neurobiol       Date:  2019-04

4.  Subjective cognitive decline and objective cognition among diverse U.S. Hispanics/Latinos: Results from the Study of Latinos-Investigation of Neurocognitive Aging (SOL-INCA).

Authors:  Zvinka Z Zlatar; Wassim Tarraf; Kevin A González; Priscilla M Vásquez; María J Marquine; Richard B Lipton; Linda C Gallo; Tasneem Khambaty; Donglin Zeng; Marston E Youngblood; Mayra L Estrella; Carmen R Isasi; Martha Daviglus; Hector M González
Journal:  Alzheimers Dement       Date:  2021-05-31       Impact factor: 16.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.